Annick D Abbeele

Annick D Van den Abbeele

UNVERIFIED PROFILE

Are you Annick D Van den Abbeele?   Register this Author

Register author
Annick D Abbeele

Annick D Van den Abbeele

Publications by authors named "Annick D Van den Abbeele"

82Publications

2840Reads

46Profile Views

1PubMed Central Citations

Evolution of Transarterial Chemoembolization for the Treatment of Liver Cancer.

Radiology 2019 Dec 15;293(3):704-706. Epub 2019 Oct 15.

From the Department of Radiology and Research Institute of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu Seoul 138-736, Republic of Korea (K.W.K.); and Department of Imaging and Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute; Department of Radiology, Brigham Health, Harvard Medical School, Boston, Mass (A.D.V.d.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2019192090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900203PMC
December 2019

Development and validation of a new MRI simulation technique that can reliably estimate optimal in vivo scanning parameters in a glioblastoma murine model.

PLoS One 2018 23;13(7):e0200611. Epub 2018 Jul 23.

Department of Imaging, Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0200611PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056046PMC
January 2019

Surveillance Imaging in Patients With Endometrial Cancer in First Remission.

Curr Probl Diagn Radiol 2018 Sep 24;47(5):311-316. Epub 2017 Aug 24.

Department of Imaging, Dana-Farber Cancer Institute, Boston, MA; Department of Radiology, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/j.cpradiol.2017.08.003DOI Listing
September 2018

Guidance on Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division.

J Nucl Med Technol 2018 Sep 3;46(3):237-244. Epub 2018 Aug 3.

Department of Imaging and Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnmt.118.209148DOI Listing
September 2018

Cancer Imaging Fellowship Training: Utility and Added Value in the Modern Era.

J Am Coll Radiol 2017 10 8;14(10):1345-1348. Epub 2017 Jul 8.

Department of Imaging, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; and the Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2017.06.005DOI Listing
October 2017

Ovarian Cancer: An Evidence-Based, Easy-to-Use Prediction Rule to Optimize the Use of Follow-up Chest CT.

J Am Coll Radiol 2017 Apr 6;14(4):499-508. Epub 2016 Oct 6.

Department of Radiology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2016.08.010DOI Listing
April 2017

Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.

J Neurooncol 2016 12 30;130(3):495-503. Epub 2016 Aug 30.

Department of Radiology, Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2243-5DOI Listing
December 2016

Cancer Imaging at the Crossroads of Precision Medicine: Perspective From an Academic Imaging Department in a Comprehensive Cancer Center.

J Am Coll Radiol 2016 Apr 14;13(4):365-71. Epub 2016 Jan 14.

Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2015.11.002DOI Listing
April 2016

Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events.

Radiographics 2015 Mar-Apr;35(2):424-37

From the Department of Radiology, University of Colorado School of Medicine, Anschutz Medical Campus, 12700 E 19th Ave, Room C278, Aurora, CO 80045 (J.J.K., P.J.K.); and Department of Imaging, Dana-Farber Cancer Institute, and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (S.H.T., A.D.V.d.A., H.A.J.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.352140121DOI Listing
January 2016

Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome.

Clin Nucl Med 2016 Jan;41(1):e7-13

From the *Department of Imaging, Dana-Farber Cancer Institute, †Department of Radiology, Brigham and Women's Hospital, and ‡Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000902DOI Listing
January 2016

Advanced High-Grade Serous Ovarian Cancer: Frequency and Timing of Thoracic Metastases and the Implications for Chest Imaging Follow-up.

Radiology 2015 Dec 5;277(3):733-40. Epub 2015 Jun 5.

From the Department of Radiology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, 75 Francis St, Boston, MA 02115 (A.B.S., A.C.O., B.S., S.H.T., M.N., A.D.V.d.A., N.H.R.); and Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Mass (S.C.).

View Article

Download full-text PDF

Source
http://pubs.rsna.org/doi/10.1148/radiol.2015142467
Publisher Site
http://dx.doi.org/10.1148/radiol.2015142467DOI Listing
December 2015

Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma.

Cancer 2015 Nov 11;121(22):4007-15. Epub 2015 Aug 11.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29622DOI Listing
November 2015

Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT.

Clin Nucl Med 2015 Nov;40(11):e528-9

From the Department of Imaging, Dana-Farber Cancer Institute; Department of Radiology, Brigham and Women's Hospital; and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000940DOI Listing
November 2015

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

J Clin Oncol 2015 Aug 13;33(24):2623-31. Epub 2015 Jul 13.

Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534525PMC
August 2015

Cancer Imaging Training in the 21st Century: An Overview of Where We Are, and Where We Need To Be.

J Am Coll Radiol 2015 Jul;12(7):714-20

Department Radiology, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts; Department Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2015.03.044DOI Listing
July 2015

[(18)F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments.

Transl Oncol 2015 Jun;8(3):147-53

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2015.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487789PMC
June 2015

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer.

Clin Genitourin Cancer 2015 Apr 22;13(2):113-23. Epub 2014 Oct 22.

Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418946PMC
April 2015

(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer.

Am J Nucl Med Mol Imaging 2015 15;5(1):72-82. Epub 2014 Dec 15.

Dana-Farber Cancer Institute, Harvard Medical School Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299771PMC
January 2015

What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.

Radiographics 2013 Nov-Dec;33(7):2003-17

From the Division of Breast Imaging, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, RA Bldg, RA-014, Boston, MA 02115 (E.D.Y., R.L.B., D.G.S., C.S.G.); and Department of Imaging (H.A.J., A.D.V.d.A.), Department of Radiation Oncology (J.R.B.), Department of Surgery (F.N.), Department of Breast Oncology (B.O.), and Inflammatory Breast Cancer Program (E.D.Y., H.A.J., J.R.B., F.N., J.H.B., B.O.), Dana-Farber Cancer Institute, Boston, Mass.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.337135503DOI Listing
June 2014

10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation study.

Oncologist 2014 May 22;19(5):507-14. Epub 2014 Apr 22.

Department of Imaging, Dana-Farber Cancer Institute, and Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA; Kidney Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012965PMC
May 2014

Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

J Clin Oncol 2014 Apr 24;32(12):1202-9. Epub 2014 Mar 24.

Ingrid A. Mayer, Vandana G. Abramson, Justin M. Balko, María Gabriela Kuba, Melinda E. Sanders, and Carlos L. Arteaga, Vanderbilt University, Nashville, TN; Steven J. Isakoff, Massachusetts General Hospital, Boston, MA; Andres Forero, University of Alabama, Birmingham, AL; Jeffrey T. Yap, Huntsman Cancer Institute, Salt Lake City, UT; Annick D. Van den Abbeele and Eric Winer, Dana-Farber Cancer Institute, Boston, MA; Yisheng Li, MD Anderson Cancer Center, Houston, TX; and Lewis C. Cantley, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/03/18/JCO.2013.54
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.0518
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.0518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986383PMC
April 2014

Voxelwise single-subject analysis of imaging metabolic response to therapy in neuro-oncology.

Stat 2014 Jan;3(1):172-186

Department of Statistics, North Carolina State University, 2311 Stinson Drive, Raleigh, NC 27615.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sta4.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078880PMC
January 2014

End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.

Clin Cancer Res 2013 Dec 19;19(23):6566-77. Epub 2013 Sep 19.

Authors' Affiliations: Center for Evaluation Value and Risk in Health, The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center; Departments of Imaging and Medical Oncology, Dana-Farber Cancer Institute; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1511DOI Listing
December 2013

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.

J Clin Oncol 2013 Sep 17;31(26):3182-90. Epub 2013 Jun 17.

F. Stephen Hodi, Anita Giobbie-Hurder, Philip Friedlander, Jason J. Luke, Katherine A. Zukotynski, Jeffrey T. Yap, Annick D. Van den Abbeele, and George D. Demetri, Dana-Farber Cancer Institute; Jonathan A. Fletcher, Meijun Zhu, and Adrian Marino-Enriquez, Brigham and Women's Hospital; Donald Lawrence, Keith T. Flaherty, and David E. Fisher, Massachusetts General Hospital, Boston, MA; Christopher L. Corless, Michael C. Heinrich, and Carol Beadling, Portland Veterans Administration Medical Center and Oregon Health & Science University, Portland, OR; Philip Friedlander, Mount Sinai Medical Center, New York, NY; Rene Gonzalez, University of Colorado Cancer Center, Aurora, CO; Jeffrey S. Weber, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Thomas F. Gajewski, University of Chicago, Chicago, IL; Steven J. O'Day, Beverly Hills Cancer Center, Beverly Hills, CA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Frances A. Collichio, The University of North Carolina at Chapel Hill, Chapel Hill, NC; and Marc S. Ernstoff, Geisel School of Medicine and Norris Cotton Cancer Center, Hanover, NH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.7836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878082PMC
September 2013

Atypical metastases from prostate cancer: 10-year experience at a single institution.

AJR Am J Roentgenol 2012 Aug;199(2):367-72

Department of Imaging, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, 450 Brookline Ave, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.11.7533DOI Listing
August 2012

Hereditary cancer syndromes: a radiologist's perspective.

AJR Am J Roentgenol 2011 Dec;197(6):W1001-7

Department of Imaging, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.11.6465DOI Listing
December 2011

Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center.

Cancer 2011 Aug 11;117(16):3860-6. Epub 2011 Feb 11.

Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25941DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131455PMC
August 2011

Imaging in renal cell carcinoma.

Hematol Oncol Clin North Am 2011 Aug;25(4):687-715

Department of Imaging, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898588110004
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2011.04.005DOI Listing
August 2011

Breast angiosarcoma metastatic to the ovary.

Case Rep Med 2009 24;2009:381015. Epub 2009 Jun 24.

Department of Radiology, Dana-Farber Cancer Institute, Harvard Medical school, 44 Binney Street, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2009/381015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729273PMC
July 2011

Imaging of lung cancer in the era of molecular medicine.

Acad Radiol 2011 Apr 28;18(4):424-36. Epub 2011 Jan 28.

Department of Imaging, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2010.10.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380440PMC
April 2011

Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor.

AJR Am J Roentgenol 2011 Jan;196(1):117-22

Department of Imaging, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.10.5036DOI Listing
January 2011

Imaging of extraosseous myeloma: CT, PET/CT, and MRI features.

AJR Am J Roentgenol 2010 Nov;195(5):1057-65

Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.ajronline.org/doi/10.2214/AJR.10.4384
Publisher Site
http://dx.doi.org/10.2214/AJR.10.4384DOI Listing
November 2010

Adult extragonadal germ cell tumors.

AJR Am J Roentgenol 2010 Oct;195(4):W274-80

Department of Imaging, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.09.4103DOI Listing
October 2010

Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.

AJR Am J Roentgenol 2010 Aug;195(2):281-9

Department of Imaging, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.09.4110DOI Listing
August 2010

Venous thrombosis in an outpatient oncologic center: distribution, type, and comorbidities.

Ultrasound Q 2009 Sep;25(3):145-50

Department of Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RUQ.0b013e3181b24f6fDOI Listing
September 2009

Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial.

AJR Am J Roentgenol 2009 Aug;193(2):326-32

Department of Radiology, Brigham and Women's Hospital, 1620 Tremont St., 3rd Fl., Radiology Ste., Boston, MA 02120, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.08.1565DOI Listing
August 2009

CT and PET/CT findings of T-cell lymphoma.

AJR Am J Roentgenol 2009 Aug;193(2):349-58

Department of Radiology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.08.1398DOI Listing
August 2009

Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.

Pediatr Blood Cancer 2009 Jul;52(7):767-71

Pediatric Oncology, Dana-Farber Cancer Institute and Department of Medicine, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21909DOI Listing
July 2009

F-18 FDG PET/CT in the diagnosis and management of a pericardiac paraganglioma.

Clin Nucl Med 2008 Aug;33(8):545-6

Department of Radiology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e31817dea57DOI Listing
August 2008

The lessons of GIST--PET and PET/CT: a new paradigm for imaging.

Oncologist 2008 ;13 Suppl 2:8-13

Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.13-S2-8DOI Listing
July 2008

Role of PET/CT scanning in initial and post-treatment assessment of Hodgkin disease.

J Natl Compr Canc Netw 2008 Jul;6(6):623-32

Department of Radiology, Sisli Etfal Training and Research Hospital, Istanbul, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2008.0047DOI Listing
July 2008

Infrequent Tumors of the Gastrointestinal Tract Including Gastrointestinal Stromal Tumor (GIST).

PET Clin 2008 Apr 6;3(2):207-15. Epub 2008 Dec 6.

Department of Radiology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA; Harvard Medical School, Boston, MA, USA; Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA, USA; Tumor Imaging Metrics Core, Dana-Farber/Harvard Cancer Center, 44 Binney Street, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2008.10.002DOI Listing
April 2008

Major response to imatinib mesylate in KIT-mutated melanoma.

J Clin Oncol 2008 Apr;26(12):2046-51

The Melanoma Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.0707DOI Listing
April 2008

FDG-PET to Measure Response to Targeted Therapy: The Example of Gastrointestinal Stromal Tumor and Imatinib Mesylate (Gleevec).

PET Clin 2008 Jan 27;3(1):77-87. Epub 2008 Nov 27.

Department of Radiology, Sisli Etfal Training and Research Hospital, Şişli 34360, Istanbul, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2008.08.001DOI Listing
January 2008

Impact of acquisition geometry, image processing, and patient size on lesion detection in whole-body 18F-FDG PET.

J Nucl Med 2007 Dec 15;48(12):1951-60. Epub 2007 Nov 15.

Division of Nuclear Medicine, Department of Radiology, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/content/48/12/1951.full.pdf
Web Search
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.108.007369
Publisher Site
http://dx.doi.org/10.2967/jnumed.108.007369DOI Listing
December 2007

CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor.

AJR Am J Roentgenol 2007 Dec;189(6):W324-30

Massachusetts College of Pharmacy and Health Sciences, 4 Brook Rd., Unit 11, Salem, NH 03079, USA.

View Article

Download full-text PDF

Source
http://www.ajronline.org/doi/10.2214/AJR.07.2496
Publisher Site
http://dx.doi.org/10.2214/AJR.07.2496DOI Listing
December 2007

2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography of the head and neck: an atlas of normal uptake and variants.

Mol Imaging Biol 2005 May-Jun;7(3):244-56

QE II Health Sciences Centre, Dalhousie Medical School, Halifax, Nova Scotia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-005-4112-zDOI Listing
September 2005